Table 2.
Group |
Numbers (Asthma/Wheeze) |
Asthma | Wheeze | ||
---|---|---|---|---|---|
OR (95% CI); P | I2 | OR (95% CI); P | I2 | ||
Maternal obesity | |||||
By sample size | |||||
Total sample size <6000 | 3/7 | 1.60 (1.20–2.13); 0.001 | 48.6% | 1.68 (1.25–2.26); 0.001 | 73.0% |
Total sample size ≥6000 | 3/6 | 1.50 (1.34–1.66); <0.001 | 0.0% | 1.28 (1.10–149); 0.001 | 44.9% |
By region | |||||
America | 3/2 | 1.39 (1.20–1.60); <0.001 | 0.0% | 3.12 (1.74–5.13); <0.001 | 0.0% |
Asia | NA/1 | NA | NA | 1.67 (0.73–3.81); 0.223 | NA |
Europe | 3/10 | 1.63 (1.38–1.94); <0.001 | 19.4% | 1.29 (1.14–1.45); <0.001 | 56.2% |
By weight modality | |||||
Medical records | 2/4 | 1.40 (1.12–1.74); 0.003 | 0.0% | 1.24 (1.00–1.55); 0.052 | 32.7% |
Self-report | 4/9 | 1.54 (1.34–1.77); <0.001 | 32.3% | 1.48 (1.22–1.79); <0.001 | 70.4% |
By diagnosis of asthma | |||||
Doctor diagnosis | 5/5 | 1.50 (1.33–1.69); <0.001 | 23.9% | 1.48 (1.19–1.86); 0.001 | 36.1% |
Parental report | 1/8 | 1.53 (1.04–2.26); 0.032 | NA | 1.29 (1.11–1.51); 0.001 | 63.0% |
Maternal overweight | |||||
By sample size | |||||
Total sample size <6000 | 4/8 | 1.19 (0.95–1.49); 0.123 | 47.1% | 1.19 (0.95–1.49); 0.032 | 0.0% |
Total sample size ≥6000 | 3/5 | 1.21 (1.13–1.30); <0.001 | 0.0% | 1.21 (1.13–1.30); 0.022 | 41.9% |
By region | |||||
America | 2/1 | 1.20 (1.06–1.38); 0.005 | 0.0% | 1.58 (0.75–3.31); 0.226 | NA |
Asia | NA/1 | NA | NA | 1.11 (0.72–1.71); 0.635 | NA |
Europe | 5/11 | 1.21 (1.06–1.37); 0.004 | 30.9% | 1.07 (1.02–1.11); 0.003 | 0.0% |
By weight modality | |||||
Medical records | 1/3 | 1.14 (0.90–1.45); 0.282 | NA | 1.12 (1.03–1.23); 0.013 | 0.0% |
Self-report | 6/10 | 1.21 (1.12–1.31); <0.001 | 10.6% | 1.06 (1.01–1.12); 0.028 | 2.7% |
By diagnosis of asthma | |||||
Doctor diagnosis | 4/4 | 1.22 (1.14–1.31); <0.001 | 0.0% | 1.16 (1.03–1.30); 0.013 | 0.0% |
Parental report | 3/9 | 1.14 (0.86–1.51); 0.362 | 57.9% | 1.06 (1.01–1.10); 0.019 | 0.0% |
BMI, body mass index; OR, odds ratio; 95% CI, 95% confidence interval; I2, inconsistency index; NA, not available.